Treatment Research Institute Joins PHMC

Treatment Research Institute (TRI) — a leading, national nonprofit research, development, and policy organization — is merging with PHMC. TRI has integrated into PHMC’s Research & Evaluation Group, who have had a long-standing collaborative relationship involving multiple initiatives.

TRI was founded in 1992 by A. Thomas McLellan, Ph.D., with a core mission to engineer and translate research to improve substance use disorder policies and programs. The research team is deeply committed to finding practical, science-based solutions to addressing an array of addictions-related public health problems. TRI works to drive the kind of transformative change that is so deeply needed in this field. In order to effect the change that is needed, TRI works with families, schools, health care systems, courts and policy-makers to ensure that our research aligns with then needs of those most affected by substance use disorders. TRI has been singularly focused on translating research into action, and bridging the chasm to create impact. For more information, visit Treatment Research Institute.

“TRI merging into PHMC creates great opportunity for the development of research and scientific-based programs that treat substance use disorders and co-occurring mental health issues, a topic of critical importance in light of today’s opioid epidemic,” said PHMC President & CEO Richard J. Cohen.

“PHMC has always approached its work through a health equity lens, with a focus on team-based science and the need for cross-disciplinary perspectives to solve today’s most pressing public health, education, and social problems. We are excited to be joined by a team of world-class scientists who have made critical contributions to the substance abuse treatment and policy arena,” said Lisa Bond, Managing Director, PHMC’s R&E Group. “There will be greater opportunity to work across the broad PHMC enterprise, as well as directly with health care providers, insurers, criminal justice agencies, treatment providers, schools, government, and families to achieve a shared goal of influencing public awareness and use of evidence-informed responses to substance use disorders.”

TRI’s research agenda remains committed to finding practical, evidence-based approaches to address substance use disorders.

Read the full press release